semaglutide and nafld Shows Promise for Fatty Liver Disease 🟠 Semaglutide: What It Is

Research indicates that semaglutide may reduce cravings, especially for high-fat foods

This side effect often improves over time

An analysis of data recorded between 2011 and 2023 from the TriNetX database, results indicate more than 800,000 patients became new users of GLP-1 receptor agonists during the period, with a marked increase in use beginning in 2020 as weight loss benefits began to emerge

This includes semaglutide and tirzepatide, manufactured by leading pharmaceutical companies

If nausea or other GI effects remain significant at 0.25 mg, your provider may recommend staying at the initial dose for an additional two to four weeks